Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-05-20

Clinical Trial Update: A Study to Evaluate CIN-107 for the Treatment of Patients With Uncontrolled Hypertension and Chronic Kidney Disease [Phase 2]

View source ↗

Summary

Phase 2 trial update reporting the completion of CIN-107 evaluation for uncontrolled hypertension in patients with chronic kidney disease, with results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CIN-107

Snippet

Sponsor: AstraZeneca | Conditions: Uncontrolled Hypertension, Chronic Kidney Diseases | Phase 2 | Status: COMPLETED | Results posted: 2025-05-20